Principal Investigator: Elias Mossialos
Research Officer: Chantal Morel
Start Date: 01 October 2014
End Date: 31 December 2017
Region: Europe/North America
Keywords: antibiotic resistance, antibiotic development, antibiotic incentives, market entry rewards
DRIVE-AB (Driving reinvestment in research and development and responsible antibiotic use) is a project exploring new business models intended to re-ignite R&D in novel antibiotics while also helping improve conservation. It seeks a system-wide detangling of supply- and demand-related incentives to ensure improved antibiotic effectiveness over the long-term.
ÐÓ°ÉÂÛ̳ Health is an academic partner of the DRIVE-AB research project, under the Innovative Medicines Initiative’s New Drugs for Bad Bugs (ND4BB) program.
DRIVE-AB is a multi-stakeholder consortium tasked with developing innovative strategies for encouraging development of new antibiotics in a way that is equitable and sustainable.
The consortium is made up of 16 public and 7 private partners from 12 countries and is funded by the Innovative Medicines Initiative, a joint undertaking between the European Union and the European Pharmaceutical Industry Association.
Fostering development of new antibiotics is a critical component in the global battle against antimicrobial resistance because there are few drugs currently in development that could replace the increasingly in-effective antibiotics we rely on every day to treat serious infections.
ÐÓ°ÉÂÛ̳ Health provides expertise in the design of economic incentives that can be used to guide, support and reward developers of new antibiotics. In particular, ÐÓ°ÉÂÛ̳ Health has been collaborating with policy makers and industry representatives to create a market entry reward that can be offered to developers who successfully make a valuable antibiotic approved for use in clinical settings.
Outputs
DRIVE-AB’s final report and recommendations, along with ÐÓ°ÉÂÛ̳ Health's work on market entry rewards, are expected to be released in early 2018.
To read more about the project's findings and outputs, visit the DRIVE-AB project website .